PDMR Notification

RNS Number : 7041L

Oncimmune Holdings PLC

23 April 2018

 

23 April 2018

Oncimmune Holdings plc

("Oncimmune" or the "Company")

PERSONS DISCHARGING MANAGER RESPONSIBILITIES (PDMR) NOTIFICATION

Oncimmune Holdings plc (AIM: ONC.L), a leading early cancer detection company developing and commercialising its proprietary EarlyCDT® platform technology, today announces that on 22 April 2018, share options over 493,531 £0.01 ordinary shares of the Company were awarded to a director (who is a PDMR), staff and a consultant under the Company's 2016 Share Option Plan (an amalgamation of the Company's 2005 and 2007 Share Option Plans) and the USA Incentive Stock Option Plan.

Name	Position	Number of Share Options Awarded	Exercise price per Share	Percentage of issued ordinary share capital
Adam Hill	Chief Medical Officer and Chief Strategy Officer	396,825	£1.26	0.58%
Other employees and a consultant (not directors or PDMR's)		96,706	£1.26	0.14%

The options are subject to the rules of the 2016 Share Option Plan and the USA Incentive Stock Option Plan and vest in five equal annual parts, the first fifth vesting on 22 April 2019 and each year thereafter for a further four years, subject to continued employment. All these options are exercisable at £1.26 pence, being the mid-market price of the Company's ordinary shares at the close of day on 20 April 2018.

For further information:

Oncimmune Holdings plc

Geoffrey Hamilton-Fairley, Chief Executive Officer

[e-mail]

Zeus Capital Limited (Nominated Adviser and Broker)

Giles Balleny

[phone]

Media enquiries:

Consilium Strategic Communications

Chris Gardner, Mary-Jane Elliott, Matthew Neal, Lindsey Neville

[e-mail]

[phone]

1	Details of the person discharging managerial responsibilities/person closely associated
a)	Name	Adam Hill
2	Reason for the notification
a)	Position/status	Chief Medical Officer and Chief Strategy Officer
b)	Initial notification/Amendment	Initial Notification
3	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)	Name	Oncimmune Holdings plc
b)	LEI	213800HCYIWT6YPI1I02
4	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)	Description of the financial instrument, type of instrument Identification code	options over 1p ordinary shares - 2016 Share Option Plan ISIN GB00BYQ94H38
b)	Nature of the transaction	Grant of options over ordinary shares
c)	Price(s) and volume(s)	Price(s) Volume(s) N/A 396,825
d)	Aggregated information	Price(s) Volume(s) N/A 396,825
e)	Date of the transaction	20 April 2018
f)	Place of the transaction	N/A

 

END

 

 

DSHZMGZDZZVGRZZ